Francesco Merolla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francesco Merolla has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Angela Celetti
CNR - Institute of Endotypes in Oncology, Metabolism and Immunology "G Salvatore" -IEOMI- Naples, Italy. Naples Italy
1 shared publication - Caterina Miro
Istituto per l'Endocrinologia e l'Oncologia Sperimentale IEOS CNR via Pansini 5 80131 Naples Italy
1 shared publication - Francesco Morra
Institute of Experimental Endocrinology and Oncology (IEOS), CNR, 80131 Naples, Italy
1 shared publication - Virginia Napolitano
Department of Advanced Biomedical Sciences, Pathology Section, University of Naples “Federico II”, 80131 Naples, Italy
1 shared publication
Latest Publications
- Open Access
- 1 September 2017
- Published by INIST-CNRS in Atlas of Genetics and Cytogenetics in Oncology and Haematology
- No. 4
CCDC6 (coiled-coil domain containing 6)
CCDC6 gene product is a pro-apoptotic protein substrate of ATM whose loss or inactivation enhances tumor progression. In primary tumors the impaired function of CCDC6 protein has been ascribed to CCDC6 rearrangements, to somatic mutations and to CCDC6 different levels in several neoplasia. The CCDC6 turnover is regulated in a cell cycle dependent manner upon post-translational modification events. The impairment of CCDC6 turnover may affect cells behaviour and drug response.
- 1 September 2017
- Published by INIST-CNRS in Atlas of Genetics and Cytogenetics in Oncology and Haematology
- No. 4
Open AccessCCDC6 (coiled-coil domain containing 6)
CCDC6 gene product is a pro-apoptotic protein substrate of ATM whose loss or inactivation enhances tumor progression. In primary tumors the impaired function of CCDC6 protein has been ascribed to CCDC6 rearrangements, to somatic mutations and to CCDC6 different levels in several neoplasia. The CCDC6 turnover is regulated in a cell cycle dependent manner upon post-translational modification events. The impairment of CCDC6 turnover may affect cells behaviour and drug response.